Find in Library
Search millions of books, articles, and more
Indexed Open Access Databases
Correction: Patient-reported outcomes of upadacitinib versus abatacept in patients with rheumatoid arthritis and an inadequate response to biologic disease-modifying antirheumatic drugs: 12- and 24-week results of a phase 3 trial
oleh: Martin Bergman, Namita Tundia, Naomi Martin, Jessica L. Suboticki, Jayeshkumar Patel, Debbie Goldschmidt, Yan Song, Grace C. Wright
Format: | Article |
---|---|
Diterbitkan: | BMC 2022-11-01 |
Deskripsi
No description available for this item.